AGGREGA PHARMA, LLC FDA Approval ANDA 215825

ANDA 215825

AGGREGA PHARMA, LLC

FDA Drug Application

Application #215825

Application Sponsors

ANDA 215825AGGREGA PHARMA, LLC

Marketing Status

Prescription001

Application Products

001SOLUTION;INTRAVENOUS50MG/ML (50MG/ML)0EPHEDRINE SULFATEEPHEDRINE SULFATE

FDA Submissions

UNKNOWN; ORIG1AP2022-04-21STANDARD

Submissions Property Types

ORIG1Null31

TE Codes

001PrescriptionAP

CDER Filings

AGGREGA PHARMA, LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215825
            [companyName] => AGGREGA PHARMA, LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"EPHEDRINE SULFATE","activeIngredients":"EPHEDRINE SULFATE","strength":"50MG\/ML (50MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/21\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-04-21
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.